Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
XoGlo by Kimera Labs for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
XoGlo is under clinical development by Kimera Labs and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia. According...